Finally, as BS has been shown to effectively normalize all these parameters, we suggest that plasma MMP-9 and PBMCs AMPK activities might potentially be used as markers of cardiovascular risk in patients with morbid obesity. This evidence concerns the gene MMP9 and morbid obesity.